Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081715 | SCV000113646 | likely benign | not specified | 2016-11-09 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001093742 | SCV000358428 | likely benign | Nephronophthisis 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000331197 | SCV000358429 | likely benign | Senior-Loken syndrome 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Gene |
RCV001573175 | SCV000513952 | likely benign | not provided | 2018-03-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22550138, 26260382) |
Labcorp Genetics |
RCV000292444 | SCV000556431 | benign | Nephronophthisis | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081715 | SCV002071208 | likely benign | not specified | 2019-07-17 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294019 | SCV002587744 | uncertain significance | Kidney disorder | 2017-05-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498430 | SCV002808941 | likely benign | Nephronophthisis 4; Senior-Loken syndrome 4 | 2022-04-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573175 | SCV004128041 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | NPHP4: BP4, BS2 |
Breakthrough Genomics, |
RCV001573175 | SCV005258127 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Sydney Genome Diagnostics, |
RCV000292444 | SCV001449373 | uncertain significance | Nephronophthisis | 2019-07-23 | no assertion criteria provided | clinical testing | This individual is also heterozygous for the c.3329C>T variant in the NPHP4 gene, which results in the amino acid substitution of alanine to valine at residue 1110, p.(Ala1110Val). To our knowledge, this variant has not been previously reported in the literature or any disease specific databases to be a disease causing variant. The variant is listed in ClinVar multiple times as both a benign variant and a VOUS. This variant has been reported in the gnomAD browser (http://gnomad.broadinstitute.org) with a low allele frequency of 0.36% (998 out of 276,100 alleles including 3 homozygous individuals). In silico analysis of pathogenicity (through Alamut Visual v2.8.1) using PolyPhen2, SIFT and MutationTaster all suggest that this variant is likely to be benign. This variant is considered to be a VOUS according to the ACMG guidelines (Evidence used: BP4). |
Laboratory of Diagnostic Genome Analysis, |
RCV001573175 | SCV001798628 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001573175 | SCV001917546 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001573175 | SCV001927063 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573175 | SCV001964744 | likely benign | not provided | no assertion criteria provided | clinical testing |